Bone Mineral Density Concerns Should Not Discourage Use Of Contraceptive Shot Concerns about the effects of depot medroxyprogesterone acetate (DMPA)-the contraceptive shot-on bone mineral density (BMD) should not prevent clinicians from prescribing this method of contraception nor should its use be limited to two years, according to a new Committee Opinion released today by The American College of Obstetricians and Gynecologists (ACOG).
Source: www.medicalnewstoday.comThe Future For The NPA, UK The NPA has set out its plans for the future direction of the NPA. There are strategies for each of the NPA's core functions - representation, support and protection. NPA Chief Executive John Turk said: "Our members are currently operating in an environment where they are squeezed financially, yet are asked to invest in new services. The NPA will address this by creating opportunities for profitable new revenue streams and to decrease their cost base.
Source: www.medicalnewstoday.comNew Approach To Treating Endometrial Cancer Discovered By TGen And Washington University Researchers Researchers at the Translational Genomics Research Institute (TGen) has announced a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells. In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of
Medicine in St.
Source: www.medicalnewstoday.com
# posted by Network @ 10:00 AM
